Related Experiment Video
Updated: Aug 13, 2026

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development
Published on: August 10, 2015
Cell adhesion molecules and the kidney
1Division of Nephrology and Hypertension, University of South Florida, James A. Haley Veterans Hospital, Tampa 33612.
Abstract:
Cell adhesion molecules (CAMs) have been implicated in various biologic processes, including morphogenesis, immune response, and thrombosis. There are four major groups: integrins, cadherins, immunoglobulin superfamily members, and selectins. Certain CAMs are differentially expressed in the developing, normal, and cancerous kidney. Other CAMs are altered in glomerulonephritis and transplant rejection. Preliminary studies suggest that blocking CAMs can attenuate tissue damage in human transplant rejection and animal models of glomerulonephritis. The study of CAMs in relation to the kidney is providing further insight into the normal and diseased kidney, and may lead to feasible new treatments for patients with renal diseases.
Insights
Cell adhesion molecules (CAMs) are crucial in kidney development and disease. Targeting these molecules shows promise for treating renal diseases like glomerulonephritis and transplant rejection.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Cell adhesion molecules (CAMs) regulate critical biological processes such as morphogenesis, immune response, and thrombosis.
- Four major CAM groups exist: integrins, cadherins, immunoglobulin superfamily members, and selectins.
- CAM expression patterns vary in developing, normal, and cancerous kidneys.
Purpose of the Study:
- To investigate the role of CAMs in kidney development and disease.
- To explore the potential of CAMs as therapeutic targets for renal conditions.
Main Methods:
- Analysis of CAM expression in different kidney states (developing, normal, cancerous).
- Examination of CAM alterations in glomerulonephritis and transplant rejection.
- Review of preliminary studies on CAM-blocking therapies.
Main Results:
- CAMs are differentially expressed in developing, normal, and cancerous kidneys.
- Specific CAMs are altered in conditions like glomerulonephritis and transplant rejection.
- Preliminary data suggest CAM blockade can reduce tissue damage in renal diseases.
Conclusions:
- CAMs play a significant role in kidney physiology and pathology.
- Understanding CAMs offers insights into normal and diseased kidney function.
- Targeting CAMs may provide novel therapeutic strategies for renal diseases.
Related Concept Videos
Overview of Cell-Matrix Interactions
Adherens Junctions
Adherens Junctions are Dynamic
The endothelial cells...
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...
Selectins
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...

